5Chen I S, Chang C T, Sheen W S, et al. Coumarins and antiplatelet aggregation constituents from Formosan Peucedanum japonicum [J]. Phytochemistry, 1996, 41 (2): 525-530.
6Roussaki M, Zelianaios K, Kavetsou E, et al. Structural modifications of coumarin derivatives: determination of antioxidant and lipoxygenase (LOX) inhibitory activity [J]. Bioorg Med Chem, 2014, 22(23): 6586-6594.
7Kumar S, Singh B K, Kalra N, et al. Novel thiocoumarins as inhibitors of TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs) and microsomal lipid peroxidation [J]. Bioorg Med Chem, 2005, 13(5): 1605-1613.
8Hlubucek, J, Ritchie E, Taylor W C. Synthesis of 2, 2-dimethylchromenes [J]. Aust J Chem, 1971, 10(17): 2347-2354.
9Murray R D H, Ballantyne M M, Mathai K P. Claisen rearrangements--Ill: convenient synthesis of the coumarins, osthenol, demethylsuberosin and coumurrayin [J]. Tetrahedron, 1971, 27(6), 1247-1251.
10Xie L, Takeuchi ~, Cosentino M L, et al. Anti-AIDS agents. 37. synthesis and structure activity relationships of (3'R,4'R)-(+)-cis-khellactone derivatives as novel potent anti-HIV agems [J]. J Med Chem, 1999, 42(14): 2662-2672.
